<DOC>
	<DOCNO>NCT00006043</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness temozolomide treat patient metastatic germ cell tumor respond cisplatin .</brief_summary>
	<brief_title>Temozolomide Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded Cisplatin</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy temozolomide patient cisplatin refractory metastatic germ cell tumor . II . Determine safety treatment patient . OUTLINE : Patients receive oral temozolomide day 1-5 . Treatment repeat every 28 day maximum 6 course absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 14-25 patient accrue study 25 month .</detailed_description>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm metastatic germ cell tumor Seminoma OR Nonseminoma Measurable disease Abnormalities radiograph OR Alpha fetoprotein great 15 ng/mL OR Beta human chorionic gonadotropin great 2.2 mIU/L At least one measurable disease site receive prior radiotherapy Refractory prior cisplatin fail , eligible , refuse autologous bone marrow transplantation PATIENT CHARACTERISTICS : Age : 16 Performance status : Karnofsky 70100 % Life expectancy : At least 3 month Hematopoietic : WBC least 3,000/mm3 Absolute neutrophil count least 1,000/mm3 Platelet count l 80,000/mm3 Hemoglobin least 10 g/dL Hepatic : Bilirubin great 1.5 time normal Transaminases great 1.5 time upper limit normal ( ULN ) Alkaline phosphatase great 3.0 time ULN Renal : Creatinine great 1.5 time ULN Other : No medical condition would interfere swallow cause excessive vomit No second malignancy except basal squamous cell skin cancer Not pregnant nursing Negative pregnancy test Fertile patient must use effective barrier contraception PRIOR CONCURRENT THERAPY : Biologic therapy : See Disease Characteristics Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
</DOC>